Back to top

Commit To Buy Heron Therapeutics At $2, Earn 22.4% Annualized Using Options

Investors eyeing a purchase of Heron Therapeutics Inc (HRTX) stock, but cautious about paying the going market price of $2.80/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $2 strike, which has a bid at the time of this writing of 20 cents..

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Heron Therapeutics, Inc. (HRTX)